Mohammed T. Abou-Saleh

THE EPIDEMIOLOGY OF ALZHEIMER’S DISEASE: AN UPDATE 207besides age and the apolipoprotein gene, few risk factors havebeen shown consistently to reduce, or to increase, the risk for AD.With advances in our understanding of the brain and our geneticcode, rapid progress should be made in identifying environmentaland genetic risk factors and in studying the interaction betweenthe two.REFERENCES1. The National Institute on Aging, and Reagan Institute WorkingGroup on Diagnostic Criteria for the Neuropathological Assessmentof Alzheimer’s Disease. Consensus recommendations for thepostmortem diagnosis of Alzheimer’s disease. Neurobiol Aging 1997;18(4 Suppl): S1–2.2. Skoog I, Lernfelt B, Landahl et al. 15-year longitudinal study ofblood pressure and dementia. Lancet 1996; 347: 1141–5.3. Ross GW, Abbott RD, Petrovitch H et al. Frequency andcharacteristics of silent dementia among elderly Japanese-Americanmen. The Honolulu–Asia Aging Study. J Am Med Assoc 1997; 12:800–5.4. American Psychiatric Association. Diagnostic and Statistical Manualof Mental Disorders, 4th edn (DSM-IV). Washington, DC: AmericanPsychiatric Association, 1994.5. World Heath Organization. International Classification of Diseases,10th edn (ICD-10). WHO: Geneva, 1988.6. McKhann G, Drachman D, Folstein M et al. Clinical diagnosis ofAlzheimer’s disease: report of the NINCDS–ADRDA Work Groupunder the auspices of Department of Health and Human ServicesTask Force on Alzheimer’s Disease. Neurology 1984; 34: 939–44.7. Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V. The effect ofdifferent diagnostic criteria on the prevalence of dementia. N Engl JMed 1997; 337: 1667–74.8. O’Connor DW, Blessed G, Cooper B et al. Cross-national interraterreliability of dementia diagnosis in the elderly and factors associatedwith disagreement. Neurology 1996; 47: 1194–9.9. van Duijn CM, Hofman A (eds). Risk factors for Alzheimer’s disease:a collaborative re-analysis of case-control studies. Int J Epidemiol1991; 20(suppl 2): S2–73.10. Hofman A, Rocca WA, Brayne C et al. The prevalence of dementia inEurope. A collaborative study of 1980–1990 prevalence findings. Int JEpidemiol 1991; 20: 736–48.11. Jorm AF, Jolley D. The incidence of dementia: a meta-analysis.Neurology 1998; 51: 728–33.12. White L, Petrovitch H, Ross GW et al. Prevalence of dementia inolder Japanese-American men in Hawaii: the Honolulu–Asia AgingStudy. J Am Med Assoc 1996; 226: 955–60.13. Skoog I, Nilsson L, Palmertz B et al. A population-based study ofdementia in 85 years-olds. N Engl J Med 1993; 328: 153–8.14. Andersen K, Launer LJ, Dewey ME et al. Sex differences in theincidence of Alzheimer’s and vascular dementia: the EURODEMStudies. Neurology (in press).15. Rocca WA, Cha RH, Waring SC, Kokmen E. Incidence of dementiaand Alzheimer’s disease. A reanalysis of data from Rochester,Minnesota, 1975–1984. Am J Epidemiol 1998; 148: 51–62.16. Bachman DL, Wolf PA, Linn RT et al. Incidence of dementia andprobable Alzheimer’s disease in a general population: theFramingham Study. Neurology 1993; 43: 515–19.17. Mortimer JA, Graves AB. Education and other socioeconomicdeterminants of dementia and Alzheimer’s disease. Neurology 1993;43(suppl 4): S39–44.18. Katzman R. Education and the prevalence of dementia andAlzheimer’s disease. Neurology 1993; 43: 13–20.19. Fratiglioni L, Grut M, Forsell Y et al. Prevalence of Alzheimer’sdisease and other dementia in an elderly urban population:relationship with age, sex and education. Neurology 1991; 41:1886–92.20. Beard M, Kokmen E, Offord K, Kurland L. Lack of associationbetween Alzheimer’s disease and education, occupation, maritalstatus or living arrangement. Neurology 1992; 42: 2063–8.21. Stern Y, Gurland B, Tatamichi TK et al. Influence of education andoccupation on the incidence of Alzheimer’s disease. J Am Med Assoc1994; 271(3): 1004–10.22. Letenneur L, Launer LJ, Andersen K et al. Education and the risk forAlzheimer’s disease: sex makes a difference. EURODEM pooledanalyses. Am J Epidemiol 2000; 51: 1064–71.23. Fratiglioni L, Ahlbom A, Viitanen M et al. Risk factors for late-onsetAlzheimer’s disease: a population-based case-control study. AnnNeurol 1993; 33: 258–66.24. O’Meara ES, Kukull WA, Sheppard L et al. Head injury and risk ofAlzheimer’s disease by apolipoprotein E genotype. Am J Epidemiol1997; 146: 373–84.25. Mayeux R, Ottman R, Tang M-X et al. Genetic susceptibility andhead injury as risk factors for Alzheimer’s disease among communitydwellingelderly persons and their first-degree relatives. Ann Neurol1993; 33: 494–501.26. Plassman BL, Havlik RJ, Steffens DC et al. Documented head injuryin early adulthood and risk of Alzheimer’s disease and otherdementias. Neurology 2000; 55(8): 1158–66.27. Mayeux R, Ottman R, Maestre G et al. Synergistic effects oftraumatic head injury and apolipoprotein epsilon-4 in patients withAlzheimer’s disease. Neurology 1995; 45: 555–7.28. Mehta KM, Ott A, Kalmijn S et al. Head trauma and risk ofdementia and Alzheimer’s disease. The Rotterdam Study. Neurology1999; 53: 1959–62.29. Erkinjuntti T, Hachinski V. Rethinking vascular dementia.Cerebrovasc Dis 1993; 3: 3–23.30. Hofman A, Ott A, Breteler MM et al. Atherosclerosis, apolipoproteinE, and prevalence of dementia and Alzheimer’s disease in theRotterdam Study. Lancet 1997; 349: 151–4.31. Kuusisto J, Koivisto K, Mykkanen L et al. Association betweenfeatures of the insulin resistance syndrome and Alzheimer’s diseaseindependently of apolipoprotein e4 phenotype: cross sectionalpopulation-based study. Br Med J 1997; 315: 1045–9.32. Leibson CL, Rocca WA, Hanson VA et al. Risk of dementia amongpersons with diabetes mellitus: a population-based cohort study. AmJ Epidemiol 1997; 145: 301–8.33. Curb JD, Rodriguez BL, Abbott RD et al. Longitudinal associationof vascular and Alzheimer’s dementias, diabetes, and glucosetolerance. Neurology 1999; 52: 971–5.34. Ott A, Slooter AJ, Hofman A et al. Smoking and risk of dementia andAlzheimer’s disease in a population-based cohort study: theRotterdam Study. Lancet 1998; 351: 1840–3.35. Merchant C, Tang MX, Albert S et al. The influence of smoking onthe risk of Alzheimer’s disease. Neurology 1999; 52: 1408–12.36. Kalmijn S, Launer LJ, Ott A et al. Dietary fat intake and the risk forincident dementing disease: The Rotterdam Study. Ann Neurol 1997;42: 776–82.37. Henderson VW. The epidemiology of estrogen replacement therapyand Alzheimer’s disease. Neurology 1997; 48(suppl 7): S27–35.38. Brenner DE, Kukull WA, Stergachis A et al. Postmenopausalestrogen replacement therapy and the risk of Alzheimer’s disease:a population-based case-control study. Am J Epidemiol 1994; 140:262–7.39. Broe GA, Henderson AS, Creasey H et al. A case—control study ofAlzheimer’s disease in Australia. Neurology 1990; 40: 1698–707.40. Graves AB, White E, Koepsel et al. A case control study ofAlzheimer’s disease. Ann Neurol 1990; 28: 766–74.41. Paganini-Hill A, Henderson VW. Estrogen deficiency and riskof Alzheimer’s disease in women. Am J Epidemiol 1994; 140:256–61.42. Tang M-X, Jacobs D, Stern K et al. Effect of oestrogen duringmenopause on risk and age at onset of Alzheimer’s disease. Lancet1996; 348: 429–32.43. Kawas C, Resnick S, Morrison A et al. A prospective study ofestrogen replacement therapy and the risk of developing Alzheimer’sdisease: the Baltimore Longitudinal Study of Aging. Neurology 1997;48: 1517–21.44. Waring SC, Rocca WA, Petersen RC et al. Postmenopausal estrogenreplacement therapy and risk of AD: a population-based study.Neurology 1999; 52: 965–70.45. Posthuma WFM, Westendorp RG, Vandenbrouchke J.Cardioprotective effect of horomone replacement therapy inpostmenopausal women: is the evidence biased? Br Med J 1994;308: 1268–9.46. McGeer PL, Rogers J. Antiinflammatory agents as theraputicapproach to Alzheimer’s disease. Neurology 1992; 42: 447–9.